Technology | Artificial Intelligence | November 20, 2018

Philips Launches IntelliSpace Discovery Research Platform at RSNA

Open platform offers radiologists comprehensive data analytics to support development and deployment of artificial intelligence assets in radiology

Philips Launches IntelliSpace Discovery Research Platform at RSNA

November 20, 2018 — Ahead of the 2018 Radiological Society of North America Annual Meeting (RSNA), Nov. 25-30 in Chicago, Philips announced the introduction of the IntelliSpace Discovery 3.0 platform. IntelliSpace Discovery 3.0 is a comprehensive, open platform to enable the development and deployment of artificial intelligence (AI) assets in radiology, with the aim to support radiologists in their clinical and translational research.

Solutions that leverage AI have the potential to improve patient care and increase the efficiency of care delivery. However, there are challenges when it comes to introducing AI into healthcare clinical practice. Health systems are consistently faced with questions on how to collect and prepare high-quality data, which methods of training and validating the tools are most appropriate, and how to deploy AI without disruption. Philips combines AI and other technologies with knowledge of the clinical and operational context in which they are used – a people-centered approach called ‘adaptive intelligence’ – to develop integrated solutions that adapt to the needs of healthcare providers.

IntelliSpace Discovery is already used for the development of radiology applications for rendering, segmentation and quantification. For example, it is being used for research and clinical validation, and subsequently the tools/applications can be deployed into the radiology workflow on the Philips IntelliSpace Portal. With the introduction of IntelliSpace Discovery 3.0, the platform now provides research applications and tools for radiologists to aggregate, normalize and anonymize data, which can be visualized and annotated to ‘train’ and validate deep learning algorithms. They can then easily deploy these algorithms as plug-in apps into the research workflow to analyze new datasets and help facilitate clinical research in radiology, oncology, neurology and cardiology.

“We use IntelliSpace Discovery to bring our research activities to the next level. Everybody is talking about artificial intelligence. We are making our own deep learning AI algorithms,” said Prof. David Maintz, head of the Department of Radiology of the University Hospital Cologne in Germany.

The building blocks of IntelliSpace Discovery include:

  • Front End Applications – Integration with existing clinical infrastructure provides seamless access to vendor-agnostic and multimodality data-sets, and research advanced visualization tools allow data to be prepared and processed for AI training with existing AI tools;
  • Study Management – Fully scalable infrastructure contains a vendor-neutral research archive for structured and unstructured data, used to upload and process data;
  • Machine Learning – Research data and deployment platform obtains batch processing in a scalable, high-performance computing environment to support iterative development and validation;  
  • Clinical Research – AI assets and capabilities include multi-parametric enablement, segmentation and annotation, tumor quantification and stratification, deep learning networks and classification; and
  • Research Services – Accessibility to Philips research and development (R&D) for a range of services from consultancy to development.

Philips IntelliSpace Discovery is for research use only and cannot be used for patient diagnosis or treatment selection.

Another example of a solution showcased at RSNA that is powered by adaptive intelligence is Philips Illumeo. Pulling data from various hospital sources, this intelligent software presents a holistic view of the patient and provides relevant tools that adapt to physician needs, offering insights and standardizing their workflow based on their own preferences.

Jeroen Tas, chief innovation and strategy officer, Philips, will host a fireside session on how radiologists can integrate the power of artificial intelligence in their research workflows, taking place on Monday, Nov. 26, at 1:45 p.m. Central in the PhilipsLive! Forum in the Philips booth. He will be joined by Michael Knopp, M.D., Ph.D., director of the Wright Center of Innovation in Biomedical Imaging and a member of the Translational Therapeutics Program at the Ohio State Univeresity Comprehensive Cancer Center (OSUCCC) and Michael Perkuhn, M.D., MSc., Philips research informatics expert in the field in the field of molecular medicine and medical imaging.

Philips’ Homer Pien will also be presenting on “Adaptive Intelligence and radiology efficiency,” on Monday, Nov. 26, at 11:30 a.m. Central in the Machine Learning Showcase. Philips is also participating in a corporate symposium on “Artificial Intelligence: The impact and implications to radiology,” on Tuesday, Nov. 27 from 9:00 – 10:30 a.m. Central. The expert-led discussion will focus on the benefits of incorporating AI within the radiology space, including identification and worklist prioritization, workflow efficiency and productivity, and supporting clinical diagnosis and treatment.

For more information: www.usa.philips.com/healthcare

Related Content

Altamont’s zero-footprint solution, CaptureWare, allows Mach7’s Enterprise Imaging Platform (EIP) to ingest more DICOM and/or non-DICOM data from various sources in a facility
News | PACS | February 20, 2020
February 20, 2020 — Mach7 announced its partnership with Altamont
Chest CT imaging of patient. #coronavirus #nCoV2019 #2019nCoV #COVID19

Examples of typical chest CT findings compatible with COVID-19 pneumonia in patients with epidemiological and clinical presentation suspicious for COVID-19 infection. This image is part of the original research, Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR, published Feb. 19, 2020, in Radiology Online.

News | Computed Tomography (CT) | February 19, 2020
February 19, 2020 — In new research
Sponsored Content | Videos | Enterprise Imaging | February 19, 2020
Bill Lacy, vice president, Medical Informatics at FUJIFILM Medic...
Sponsored Content | Videos | Flat Panel Displays | February 19, 2020
EIZO medical monitors were showcased recently at RSN...
Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
The Candelis ImageGrid Plus PACS Server is an ultra-high-performance platform that can support high volume healthcare environments of 1,000 plus modalities
News | PACS | February 12, 2020
February 12, 2020 — The Candelis ImageGrid Plus...
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c